Signifor (pasireotide subcutaneous injection) — Medica

Initial criteria

• age ≥ 18 years
• According to the prescriber, the patient is not a candidate for surgery or surgery has not been curative
• The medication is prescribed by or in consultation with an endocrinologist or a physician who specializes in the treatment of Cushing’s syndrome

Reauthorization criteria

• Patient has had a response, as determined by the prescriber
• Patient is continuing therapy to maintain response

Approval duration

initial 4 months; reauthorization 1 year